ISA 2022 | Targeting oligomeric species to combat Parkinson’s disease

Daniel Otzen, PhD, Aarhus University, Aarhus, Denmark, comments on the rationale for targeting oligomeric species in Parkinson’s disease, highlighting the challenges of this approach. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.